Photo of Pharmaceutical Patents
Pharmaceutical Patents
PDF
Overview
Representative Matters
Newsroom

We offer a comprehensive national and international Abbreviated New Drug Application (ANDA) and pharmaceutical patent litigation practice. With a strong background in biochemistry, our Intellectual Property team has represented generic and brand companies in disputes relating to numerous pharmaceuticals, including several billion-dollar drug products. Our IP attorneys are routinely asked to evaluate the patent landscape and provide non-infringement, validity, and/or freedom to operate opinions with respect to pharmaceutical patents and products. Our team is well versed in claim construction discovery, briefing and Markman hearing strategies. We also have extensive experience analyzing certification letters, including Paragraph IV certification letters. M&R combines legal acumen and technical knowledge to develop innovative case strategies and maximize the strength of each claim.

We offer a comprehensive national and international Abbreviated New Drug Application (ANDA) and pharmaceutical patent litigation practice. With a strong background in biochemistry, our Intellectual Property team has represented generic and brand companies in disputes relating to numerous pharmaceuticals, including several billion-dollar drug products. Our IP attorneys are routinely asked to evaluate the patent landscape and provide non-infringement, validity, and/or freedom to operate opinions with respect to pharmaceutical patents and products. Our team is well versed in claim construction discovery, briefing and Markman hearing strategies. We also have extensive experience analyzing certification letters, including Paragraph IV certification letters. M&R combines legal acumen and technical knowledge to develop innovative case strategies and maximize the strength of each claim.